Dr. Biaggioni is Professor of Medicine and Pharmacology, the David Robertson Professor in Autonomic Disorders. His research primarily focuses on the interaction between neural (autonomic) metabolic (renin- angiotensin, insulin) and local (adenosine, nitric oxide) mechanisms involved in cardiovascular regulation, how these interactions participate in thepathophysiology of autonomic disorders, and how understanding their pathophysiology leads to the development of novel therapies. He has had continued NIH funding for over 35 years that has resulted in over 370 peer-reviewed publications. Dr. Biaggioni is the Director of the Vanderbilt Autonomic Dysfunction Center, a multidisciplinary program with expertise in Neurology (Movement Disorders, Neuromuscular Neurology and Sleep Medicine), Cardiology, Geriatrics, Internal Medicine and Clinical Pharmacology. The Center has made significant contributions, including the discovery of four congenital autonomic disorders: dopamine β-hydroxylase deficiency, CYB561 deficiency, norepinephrine reuptake deficiency, and familial autonomic ganglionopathy. The Center has contributed to the development of new medications, the repurposing of approved drugs, and developed novel devices for the treatment of patients with autonomic disorders. Dr. Biaggioni was honored as the American Heart Association’s 2021 Distinguished Scientist of the American Heart Association and the Lifetime Achievement Award of the Council on Hypertension. He is also an elected member of the Association of American Physicians and has served as president of the American Autonomic Society.